Qigen F. Fang

Neck
Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

ASO Visual Abstract: Development and Validation of a Novel Pathological Nodal Staging System for Oral Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy.

ASO Visual Abstract: Development and Validation of a Novel Pathological Nodal Staging System for Oral Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy.

Journal: Annals of surgical oncology

Published: July 19, 2026

Development and Validation of a Novel Pathologic Nodal Staging System for Oral Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy.

Development and Validation of a Novel Pathologic Nodal Staging System for Oral Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy.

Journal: Annals of surgical oncology

Published: May 11, 2026

ASCL2 promotes malignant progression in head and neck squamous cell carcinoma by transcriptionally downregulating SHPRH.

ASCL2 promotes malignant progression in head and neck squamous cell carcinoma by transcriptionally downregulating SHPRH.

Journal: Biochemical pharmacology

Published: April 04, 2026

Correction: Evaluation of ctDNA-guided adjuvant therapy de-escalation in head and neck squamous cell carcinoma: a comparative cohort study.

Correction: Evaluation of ctDNA-guided adjuvant therapy de-escalation in head and neck squamous cell carcinoma: a comparative cohort study.

Journal: Frontiers in immunology

Published: April 02, 2026

Re-authoring the altered self: the impact of a three-phase narrative nursing intervention on body image and distress in oral squamous cell carcinoma.

Re-authoring the altered self: the impact of a three-phase narrative nursing intervention on body image and distress in oral squamous cell carcinoma.

Journal: Frontiers in psychology

Published: March 02, 2026

Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery.

Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery.

Journal: Head & neck

Published: March 01, 2026

Submental Island Flap Versus Free Flap Reconstruction in Oral Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy: A Propensity Score Matched Analysis.

Submental Island Flap Versus Free Flap Reconstruction in Oral Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy: A Propensity Score Matched Analysis.

Journal: Head & neck

Published: March 01, 2026

Immune dysfunction and food-specific IgG associated erosive oral lichen planus: a two-hit pathogenic model.

Immune dysfunction and food-specific IgG associated erosive oral lichen planus: a two-hit pathogenic model.

Journal: Frontiers in immunology

Published: February 05, 2026

Stratified lymph node yield thresholds after neoadjuvant immunochemotherapy: a surgical benchmark for survival in oral squamous cell carcinoma.

Stratified lymph node yield thresholds after neoadjuvant immunochemotherapy: a surgical benchmark for survival in oral squamous cell carcinoma.

Journal: Frontiers in immunology

Published: January 07, 2026

Immunomodulation in healing: neoadjuvant immunochemotherapy reduces major wound complications and accelerates recovery in oral cancer surgery.

Immunomodulation in healing: neoadjuvant immunochemotherapy reduces major wound complications and accelerates recovery in oral cancer surgery.

Journal: Frontiers in immunology

Published: December 15, 2025

A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma.

A multimodal biological margin risk index predicts recurrence after neoadjuvant immunochemotherapy in head and neck squamous cell carcinoma.

Journal: Frontiers in immunology

Published: November 06, 2025

Breaking New Ground in Cervical Metastatic Carcinoma of Unknown Primary: Neoadjuvant Immunochemotherapy's Pathologic Regression and Survival Advantage.

Breaking New Ground in Cervical Metastatic Carcinoma of Unknown Primary: Neoadjuvant Immunochemotherapy's Pathologic Regression and Survival Advantage.

Journal: Annals of surgical oncology

Published: August 08, 2025

Showing 1-12 of 95

Last Updated: 09/26/2026